Leo pharma leverages veeva link for key people to expand engagement with scientific experts

Global medical dermatology leader aims to more effectively engage with medical communities and advance new treatments that are expected to improve patients' quality of life pleasanton, calif. , april 27, 2022 /prnewswire/ -- veeva systems (nyse: veev) today announced that it has expanded its partnership with leo pharma, a global leader in medical dermatology, to drive relevant discussions with the scientific community using veeva link for key people, a real time intelligence application from the veeva link family of data products.
VEEV Ratings Summary
VEEV Quant Ranking